About
Doug Williams has held senior leadership roles across the biotechnology industry, including Executive Vice President of Research and Development at Biogen, CEO of ZymoGenetics (which he led through its acquisition by Bristol Myers Squibb), and Chief Scientific Officer and EVP of R&D at Seattle Genetics. He previously served as Senior Vice President and Washington Site Leader at Amgen and as EVP, Chief Technology Officer, and board member at Immunex. He holds a Ph.D. from the State University of New York at Buffalo, Roswell Park Division, and completed a postdoctoral fellowship at Indiana University School of Medicine.
Invests in
Biotech
Experience
- Codiak BioSciencesCEO
- Codiak BioSciencesPresident & CEOcurrent2015 β presentCambridge, MA
- BiogenExecutive Vice President Research & Development2011 β 2015Cambridge, MA
- ZymoGeneticsCEO2009 β 2010Seattle, WA
- ZymoGeneticsPresident & Chief Scientific Officer2007 β 2008Seattle, WA
- ZymoGeneticsExecutive Vice President, Research & Development & Chief Scientific Officer2004 β 2007Seattle, WA
- Seattle GeneticsExecutive Vice President, Research & Development & Chief Scientific Officer2003 β 2004Bothell, WA
- Genesis Research & Development Corp, LtdHead of Health and Strategic Development2002 β 2003Auckland, Auckland, New Zealand
- Amgen WashingtonSenior Vice President2002Seattle, WA
- Immunex CorporationExecutive Vice President & Chief Technology Officer1999 β 2002Seattle, WA
- Immunex CorporationSenior Vice President, Discovery Research1994 β 1999Seattle, WA
- Immunex Research & Development Corp.Vice President1992 β 1994Seattle, WA
- Immunex Research & Development CorpDirector1989 β 1991Seattle, WA
- Immunex Research & Development CorpStaff Scientist1988Seattle, WA
Investments
Board seats
AC Immune SAStablix
Per the firm's website.
Colleagues at Pillar VC
Frequently asked questions
- Who is Doug Williams?
- Doug Williams has held senior leadership roles across the biotechnology industry, including Executive Vice President of Research and Development at Biogen, CEO of ZymoGenetics (which he led through its acquisition by Bristol Myers Squibb), and Chief Scientific Officer and EVP of R&D at Seattle Genetics. He previously served as Senior Vice President and Washington Site Leader at Amgen and as EVP, Chief Technology Officer, and board member at Immunex. He holds a Ph.D. from the State University of New York at Buffalo, Roswell Park Division, and completed a postdoctoral fellowship at Indiana University School of Medicine.
- Where does Doug Williams work?
- Doug Williams is Biotech Executive & Founding Pillar at Pillar VC.
- What does Doug Williams invest in?
- Doug Williams invests in Biotech.
- What boards does Doug Williams sit on?
- Doug Williams holds tracked board seats at AC Immune SA, Stablix.
- Where did Doug Williams go to school?
- Doug Williams studied at Indiana University School of Medicine (Postdoctoral Fellow, Division of Hematology/Oncology); University at Buffalo Pharmacy and Pharmaceutical Sciences (Ph.D.); Greenfield Community College (Associates Degree, Liberal Arts and Sciences/Liberal Studies).
Founder mafias
Pillar VC mafia17
Also came through, then founded or led a company.
+ 10 more
University of Massachusetts Lowell mafia4
Also came through, then founded or led a company.
Indiana University School of Medicine mafia2
Also came through, then founded or led a company.
Same school
Also attended Indiana University School of Medicine4
Also attended University at Buffalo Pharmacy and Pharmaceutical Sciences1
Also attended University of Massachusetts Lowell12
+ 6 more
Shared employers
Also worked at Biogen29
+ 23 more





























